Descrição

Autotransfusion is a medical procedure in which the lost blood of a patient is collected and returned to the same patient. It should be considered in every trauma patient while in the emergency department. Autotransfusion can also be used in patients undergoing surgery or any patient with anticipated blood loss without contraindications. The global autotransfusion device market is poised to grow by US$ 155.5 milhões durante 2022-2028, progredindo em um CAGR de 2.1% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for autotransfusion device. The global autotransfusion device market is segmented on the basis of product, aplicativo, usuário final, and region. Por produto, the global autotransfusion device market has been segmented into devices, acessórios. Based upon application, the global autotransfusion device market is categorized into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, outros. On the basis of end user, the global autotransfusion device market has been segmented into ambulatory surgery centers (ASCs), hospitais, specialty clinics. Geographically, the global autotransfusion device market is segmented into Asia Pacific, Europa, América do Norte, Rest of the World (RoW).

The global autotransfusion device market is highly competitive. Key companies profiled in the report include Advancis Surgical (Brightwake Limited), Atrium Medical Corporation (MAQUET Cardiovascular LLC), Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic PLC, Stryker Corporation, Terumo Corporation.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the autotransfusion device market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

produtos: devices, acessórios
Aplicativo: cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, outros
Usuário final: ambulatory surgery centers (ASCs), hospitais, specialty clinics
Região: Ásia-Pacífico, Europa, América do Norte, Rest of the World (RoW)
Anos considerados: este relatório cobre o período 2018 para 2028

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global autotransfusion device market
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Autotransfusion device market overview
Papel 3. Divisão de mercado por produto
– Devices
– Accessories
Papel 4. Market breakdown by application
– Cardiac surgeries
– Orthopedic surgeries
– Organ transplantation
– Trauma procedures
– Outros
Papel 5. Detalhamento do mercado por usuário final
– Ambulatory surgery centers (ASCs)
– Hospitais
– Specialty clinics
Papel 6. Market breakdown by region
– Ásia-Pacífico
– Europa
– América do Norte
– Rest of the World (RoW)
Papel 7. Principais empresas
– Advancis Surgical (Brightwake Limited)
– Atrium Medical Corporation (MAQUET Cardiovascular LLC)
– Fresenius SE & Co. KGaA
– Haemonetics Corporation
– LivaNova, PLC
– Medtronic PLC
– Stryker Corporation
– Terumo Corporation
Sobre StrategyHelix
Isenção de responsabilidade